Avidity Biosciences, Inc.
RNA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 14% | 3.6% | -1.1% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 100% | 78% | 85% | -984.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,452% | -2,442.4% | -1,924.6% | -1,259% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,957.7% | -2,219.9% | -1,886.3% | -1,265.4% |
| EPS Diluted | -2.89 | -2.91 | -3.34 | -2.85 |
| % Growth | 0.7% | 12.9% | -17.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |